Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
46
DXCM Quote, Financials, Valuation and Earnings
Last price:
$68.13
Seasonality move
:
4.69%
Day range:
$67.04 - $68.55
52-week range:
$54.11 - $93.25
Dividend yield:
0%
P/E ratio:
37.93x
P/S ratio:
6.15x
P/B ratio:
9.75x
Volume:
5.2M
Avg. volume:
5.6M
1-year change:
-21.1%
Market cap:
$26.6B
Revenue:
$4B
EPS (TTM):
$1.80
Analysts' Opinion
-
Consensus RatingDexCom, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 20 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $85.19, DexCom, Inc. has an estimated upside of 25.01% from its current price of $68.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $68.00 representing 100% downside risk from its current price of $68.15.
Fair Value
-
According to the consensus of 23 analysts, DexCom, Inc. has 25.01% upside to fair value with a price target of $85.19 per share.
DXCM vs. S&P 500
-
Over the past 5 trading days, DexCom, Inc. has underperformed the S&P 500 by -3.9% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
DexCom, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
DexCom, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter DexCom, Inc. reported revenues of $1.2B.
Earnings Growth
-
DexCom, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter DexCom, Inc. reported earnings per share of $0.70.
Enterprise value:
25.8B
EV / Invested capital:
--
Price / LTM sales:
6.15x
EV / EBIT:
33.22x
EV / Revenue:
5.72x
PEG ratio (5yr expected):
4.92x
EV / Free cash flow:
24.33x
Price / Operating cash flow:
26.15x
Enterprise value / EBITDA:
25.27x
Gross Profit (TTM):
$2.7B
Return On Assets:
10.47%
Net Income Margin (TTM):
15.96%
Return On Equity:
30.94%
Return On Invested Capital:
14.67%
Operating Margin:
20.05%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $3.4B | $4B | $4.5B | $994.2M | $1.2B | |
| Gross Profit | $2.2B | $2.4B | $2.7B | $593.8M | $747.4M | |
| Operating Income | $506.2M | $628M | $777.7M | $152M | $242.5M | |
| EBITDA | $676M | $840.4M | $1B | $207.3M | $306.1M | |
| Diluted EPS | $0.90 | $1.67 | $1.80 | $0.34 | $0.70 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.7B | $3.4B | $4.7B | $4.3B | $5.2B | |
| Total Assets | $4.8B | $4.9B | $6.6B | $6.4B | $7.5B | |
| Current Liabilities | $734.9M | $900.5M | $1.7B | $1.7B | $3.3B | |
| Total Liabilities | $2.6B | $3.1B | $4.3B | $4.4B | $4.8B | |
| Total Equity | $2.1B | $1.8B | $2.3B | $2B | $2.7B | |
| Total Debt | $1.9B | $2.1B | $2.7B | $2.6B | $2.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $747.4M | $821.7M | $1.4B | $199.5M | $659.9M | |
| Cash From Investing | -$1.1B | $511.1M | -$74.3M | $210.3M | $192.8M | |
| Cash From Financing | $312.3M | -$1.4B | -$165.8M | -$736.5M | -$175M | |
| Free Cash Flow | $499.8M | $535M | $1.1B | $88.3M | $579.4M | |
DXCM
Sector
Market Cap
$26.6B
$23.4M
Price % of 52-Week High
73.08%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
0.62%
-1.64%
1-Year Price Total Return
-21.1%
-21.81%
Beta (5-Year)
1.491
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$70.16
200-day SMA
Sell
Level
$74.22
Bollinger Bands (100)
Buy
Level
62.28 - 70.86
Chaikin Money Flow
Buy
Level
539.2M
20-day SMA
Sell
Level
$71.34
Relative Strength Index (RSI14)
Sell
Level
40.30
ADX Line
Sell
Level
23.92
Williams %R
Buy
Level
-86.6587
50-day SMA
Sell
Level
$68.74
MACD (12, 26)
Buy
Level
0.15
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
538.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.6861)
Sell
CA Score
(Annual)
Level (-0.5861)
Buy
Beneish M-Score
(Annual)
Level (-2.6928)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.0785)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Stock Forecast FAQ
In the current month, DXCM has received 20 Buy ratings 3 Hold ratings, and 0 Sell ratings. The DXCM average analyst price target in the past 3 months is $85.19.
-
Where Will DexCom, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that DexCom, Inc. share price will rise to $85.19 per share over the next 12 months.
-
What Do Analysts Say About DexCom, Inc.?
Analysts are divided on their view about DexCom, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DexCom, Inc. is a Sell and believe this share price will drop from its current level to $68.00.
-
What Is DexCom, Inc.'s Price Target?
The price target for DexCom, Inc. over the next 1-year time period is forecast to be $85.19 according to 23 Wall Street analysts, 20 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is DXCM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for DexCom, Inc. is a Buy. 20 of 23 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of DXCM?
You can purchase shares of DexCom, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DexCom, Inc. shares.
-
What Is The DexCom, Inc. Share Price Today?
DexCom, Inc. was last trading at $68.13 per share. This represents the most recent stock quote for DexCom, Inc.. Yesterday, DexCom, Inc. closed at $68.15 per share.
-
How To Buy DexCom, Inc. Stock Online?
In order to purchase DexCom, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get DXCM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DXCM
Sector
P/E ratio
37.93x
23.34x
PEG ratio
4.92x
-0.01x
P/B ratio
9.75x
1.72x
Price / LTM sales
6.15x
1.51x
Growth Metrics
DXCM
Sector
Revenue growth
21.64%
3.21%
Earnings growth
109.88%
10.12%
Revenue (5-year growth)
22.27%
6.27%
Earnings forecast
$0.65
-$0.19
Profitability
DXCM
Sector
Profitability FY 2024
$2.4B
$2.7M
Return on invested capital
14.67%
-33.62%
Return on assets
10.47%
-29.68%
Return on equity
30.94%
-38.89%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
Feb
12
Estimated Next Earnings Date
May
14
Balance Sheet
DXCM
Sector
Total cash
$3.3B
$25M
Short term investments
$2B
$23.9M
Total assets
$6.5B
$72.8M
Long term debt
$2.6B
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 12.12% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 6.32% over the past day.
Buy
73
AEHR alert for Feb 12
Aehr Test Systems [AEHR] is down 17.49% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
